Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS.

Ossenkoppele, G J; Breems, D A; Stuessi, G; van Norden, Y; Bargetzi, M; Biemond, B J; A von dem Borne, P; Chalandon, Y; Cloos, J; Deeren, D; Fehr, M; Gjertsen, B; Graux, C; Huls, G; Janssen, J J J W; Jaspers, A; Jongen-Lavrencic, M; de Jongh, E; Klein, S K; van der Klift, M; van Marwijk Kooy, M; Maertens, J; Michaux, L; van der Poel, M W M; van Rhenen, A; Tick, L; Valk, P; Vekemans, M C; van der Velden, W J F M; de Weerdt, O; Pabst, T; Manz, M; Löwenberg, B

Ossenkoppele, G J; Breems, D A; Stuessi, G; van Norden, Y; Bargetzi, M; Biemond, B J; A von dem Borne, P; Chalandon, Y; Cloos, J; Deeren, D; Fehr, M; Gjertsen, B; Graux, C; Huls, G; Janssen, J J J W; Jaspers, A; Jongen-Lavrencic, M; de Jongh, E; Klein, S K; van der Klift, M; van Marwijk Kooy, M; Maertens, J; Michaux, L; van der Poel, M W M; van Rhenen, A; Tick, L; Valk, P; Vekemans, M C; van der Velden, W J F M; de Weerdt, O; Pabst, T; Manz, M; Löwenberg, B.

Affiliation

Ossenkoppele GJ; Amsterdam University Medical Cente, location VUMC, Amsterdam, Netherlands. g.ossenkoppele@amsterdamumc.nl.
Breems DA; Netwerk Antwerpen, Antwerp, Belgium.
Stuessi G; Bellinzona-IOSI, Bellinzona, Switzerland.
van Norden Y; HOVON Data Center, Erasmus MC- Department of Hematology, Rotterdam, The Netherlands.
Bargetzi M; Aarau- Kantonsspital, Aarau, Switzerland.
Biemond BJ; Amsterdam University Medical Center, location AMC, Amsterdam, Netherlands.
A von dem Borne P; Leiden University Medical Center, Leiden, Netherlands.
Chalandon Y; University Hospital and University of Geneva, Genève, Switzerland.
Cloos J; Amsterdam University Medical Cente, location VUMC, Amsterdam, Netherlands.
Deeren D; Roeselare-AZ Delta, Roeselare, Belgium.
Fehr M; St Gallen-Kantonnsspital, St. Gallen, Switzerland.
Gjertsen B; Haukeland University Hospital, Bergen (N), Norway.
Graux C; Yvoir-MontGodinne, Yvoir, Belgium.
Huls G; University Medical Center, Groningen, Netherlands.
Janssen JJJW; Amsterdam University Medical Cente, location VUMC, Amsterdam, Netherlands.
Jaspers A; Hôpital Citadelle, Liège (B), Belgium.
Jongen-Lavrencic M; Erasmus University Medical Center, Rotterdam, Netherlands.
de Jongh E; Dordrecht ASZ, Dordrecht, Netherlands.
Klein SK; Meander Medical Center, Amersfoort, Netherlands.
van der Klift M; Amphia-Breda, Breda, Netherlands.
van Marwijk Kooy M; Isala Hospital, Zwolle, Netherlands.
Maertens J; Hospital Gasthuisberg, Leuven (B), Belgium.
Michaux L; Center for Human Genetics, KU Leuven and University Hospitals Leuven, Leuven, Belgium.
van der Poel MWM; Maastricht University Medical Center, Maastricht, Netherlands.
van Rhenen A; UMC Utrecht, Utrecht, Netherlands.
Tick L; MaximaMC Eindhoven, Eindhoven, Netherlands.
Valk P; Hôpital Citadelle, Liège (B), Belgium.
Vekemans MC; Hôpital St Luc, Bruxelles, Belgium.
van der Velden WJFM; Radboudumc Nijmegen, Nijmegen, Netherlands.
de Weerdt O; St Antonius Hospital, Nieuwegein, Netherlands.
Pabst T; Department of Oncology, University Hospital, Inselspital and University of Bern, Bern, Switzerland.
Manz M; University Hospital, Zurich, Switzerland.
Löwenberg B; Hôpital Citadelle, Liège (B), Belgium.

Leukemia ; 34(7): 1751-1759, 2020 07.

Article in En | MEDLINE | ID: mdl-32020044

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Induction Chemotherapy Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Country of publication:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google